Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
AZD-8055
85
CHF
CHF 85.00
In stock
SYN-1166-M0011 mgCHF 85.00
SYN-1166-M0055 mgCHF 142.00
SYN-1166-M01010 mgCHF 163.00
SYN-1166-M05050 mgCHF 454.00
SYN-1166-M100100 mgCHF 780.00
Product Details | |
---|---|
Synonyms | AZD8055; CCG168 |
Product Type | Chemical |
Properties | |
Formula | C25H31N5O4 |
MW | 465.5 |
CAS | 1009298-09-2 |
Purity Chemicals | ≥95% |
Appearance | Solid. |
Solubility | Soluble in DMSO or ethanol. |
Declaration | Manufactured by SynKinase. |
Other Product Data |
Target: mTOR | Kinase Group: Atypical (PIKK) | Substrate: Serine-Threonine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
InChi Key | KVLFRAWTRWDEDF-IRXDYDNUSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
AZD8055 is a novel ATP-competitive inhibitor of mTOR kinase activity with an IC(50) of 0.8nM. It shows excellent selectivity (~1,000-fold) against all class I phosphatidylinositol 3-kinase (PI3K) isoforms and other members of the PI3K-like kinase family.
Product References
- Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment: C. Garcia-Echeverria; Bioorg. Med. Chem. Lett. 20, 4308 (2010)
- Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014: K.G. Pike, et al.; Bioorg. Med. Chem. Lett. 23, 1212 (2013)